Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection

被引:57
作者
Barbour, JD
Hecht, FM
Wrin, T
Segal, MR
Ramstead, CA
Liegler, TJ
Busch, MP
Petropoulos, CJ
Hellmann, NS
Kahn, JO
Grant, RM
机构
[1] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94141 USA
[3] San Francisco Gen Hosp, San Francisco, CA 94110 USA
[4] Univ Calif San Francisco, Ctr Bioinformat & Mol Biostat, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Sch Pharm, Dept Biopharmaceut Sci, Program Biol & Med Informat, San Francisco, CA 94143 USA
[6] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[7] Blood Ctr Pacific, Blood Syst, San Francisco, CA USA
[8] ViroLogic, San Francisco, CA USA
关键词
D O I
10.1086/422036
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Infection with primary drug-resistant human immunodeficiency virus type 1 (HIV-1) has been associated with higher CD4(+) T cell counts in drug-naive patients, suggesting that altered viral pol replication capacity ( RC) associated with drug resistance diminishes immune injury in vivo, independent of exposure to drugs. Methods. Virus replication over a single cycle was measured by use of a viral test vector containing patient-derived HIV-1 protease and reverse transcriptase gene segments. Results. Among 191 recently infected patients, pol RC ranged widely, with only 6% of the variance explained by drug-resistance mutations. Patients infected with a virus with a low pol RC (less than or equal to43% of the reference virus) had significantly higher CD4(+) T cell counts at study entry, independent of drug resistance and plasma HIV-1 RNA level, and over time, both before and during combination antiretroviral therapy. Conclusions. Viral pol RC may influence HIV-1 disease progression by affecting the amount and tissue distribution of viral replication. The pol RC value of 43% may represent a threshold below which HIV-1 has lowered virulence and is less able to deplete CD4(+) T cell counts.
引用
收藏
页码:251 / 256
页数:6
相关论文
共 23 条
[1]   Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults [J].
Barbour, JD ;
Wrin, T ;
Grant, RM ;
Martin, JN ;
Segal, MR ;
Petropoulos, CJ ;
Deeks, SG .
JOURNAL OF VIROLOGY, 2002, 76 (21) :11104-11112
[2]  
BARBOUR JD, 2003, ANTIVIR THER, pS80
[3]   Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. [J].
Deeks, SG ;
Wrin, T ;
Liegler, T ;
Hoh, R ;
Hayden, M ;
Barbour, JD ;
Hellmann, NS ;
Petropoulos, CJ ;
McCune, JM ;
Hellerstein, MK ;
Grant, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) :472-480
[4]   Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia [J].
Deeks, SG ;
Barbour, JD ;
Grant, RM ;
Martin, JN .
AIDS, 2002, 16 (02) :201-207
[5]   Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response [J].
Deeks, SG ;
Grant, RM ;
Wrin, T ;
Paxinos, EE ;
Liegler, T ;
Hoh, R ;
Martin, JN ;
Petropoulos, CJ .
AIDS, 2003, 17 (03) :361-370
[6]   Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection [J].
Deeks, SG ;
Barbour, JD ;
Martin, JN ;
Swanson, MS ;
Grant, RM .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (03) :946-953
[7]   HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: Response to both initial and salvage therapy [J].
Deeks, SG ;
Hecht, FM ;
Swanson, M ;
Elbeik, T ;
Loftus, R ;
Cohen, PT ;
Grant, RM .
AIDS, 1999, 13 (06) :F35-F43
[8]  
Diggle PJ., 2002, ANAL LONGITUDINAL DA
[9]   TREATMENT WITH LAMIVUDINE, ZIDOVUDINE, OR BOTH IN HIV-POSITIVE PATIENTS WITH 200 TO 500 CD4+ CELLS PER CUBIC MILLIMETER [J].
ERON, JJ ;
BENOIT, SL ;
JEMSEK, J ;
MACARTHUR, RD ;
SANTANA, J ;
QUINN, JB ;
KURITZKES, DR ;
FALLON, MA ;
RUBIN, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1662-1669
[10]   Time trends in primary HIV-1 drug resistance among recently infected persons [J].
Grant, RM ;
Hecht, FM ;
Warmerdam, M ;
Liu, L ;
Liegler, T ;
Petropoulos, CJ ;
Hellmann, NS ;
Chesney, M ;
Busch, MP ;
Kahn, JO .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (02) :181-188